A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia

Clinical trial NCT00220311 · COMPLETED

Trial details

NCT number: NCT00220311
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Leukemia, Lymphocytic, Chronic, B-Cell

Start date: 2000-11-01
Primary completion: 2005-09-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.